DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.
HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for Dantrium® vials as follows: Dantrium® Vials Dantrolene sodium hemiheptahydrate 20mg ARTG 14435 Normal supplies are expected to resume by the end…
Read more
Further to DrugAlert vol 1041, HPS Pharmacies wish to provide an update on the availability of Palexia® IR as follows: Palexia® IR 50mg Tablets Tapentadol (as hydrochloride) 50 mg ARTG 165310 The short-term supply…
Read more
HPS Pharmacies wish to advise that Seqirus is experiencing a supply interruption for Palexia® IR as follows: Palexia® IR 50mg Tablets Tapentadol (as hydrochloride) 50 mg ARTG 165310 This supply interruption is due to…
Read more
HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for Prostin® E2 as follows: Prostin® E2 Vaginal Gel Dinoprostone 1mg ARTG 9983 Prostin® E2 Vaginal Gel Dinoprostone 2mg ARTG 9984 Normal…
Read more
HPS Pharmacies wish to advise that all brands are experiencing a supply interruption for salbutamol 5mg nebules as follows: Ventolin® Nebules Salbutamol 5mg/2.5mL ARTG 12534 Salbutamol Cipla Inhalation Ampoules Salbutamol 5mg/2.5mL ARTG 115657 Normal…
Read more
HPS Pharmacies wish to give notice that Smith & Nephew has discontinued Flamazine® cream as follows: Flamazine® Cream Jar Silver sulfadiazine 1.0% w/w, 500g ARTG 159338 Flamazine® Cream Tube Silver sulfadiazine 1.0%…
Read more
